CH632252A5 - Process for preparing novel prostaglandin analogues - Google Patents

Process for preparing novel prostaglandin analogues Download PDF

Info

Publication number
CH632252A5
CH632252A5 CH951377A CH951377A CH632252A5 CH 632252 A5 CH632252 A5 CH 632252A5 CH 951377 A CH951377 A CH 951377A CH 951377 A CH951377 A CH 951377A CH 632252 A5 CH632252 A5 CH 632252A5
Authority
CH
Switzerland
Prior art keywords
carbon atoms
alkyl
formula
phenyl
hydrogen
Prior art date
Application number
CH951377A
Other languages
German (de)
English (en)
Inventor
Gordon Leonard Bundy
David Charles Peterson
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/810,811 external-priority patent/US4112224A/en
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CH632252A5 publication Critical patent/CH632252A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CH951377A 1976-08-16 1977-08-16 Process for preparing novel prostaglandin analogues CH632252A5 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71439076A 1976-08-16 1976-08-16
US05/810,811 US4112224A (en) 1976-08-16 1977-06-30 Biheterocyclic-9,11-trideoxy-PGF compounds

Publications (1)

Publication Number Publication Date
CH632252A5 true CH632252A5 (en) 1982-09-30

Family

ID=27109143

Family Applications (2)

Application Number Title Priority Date Filing Date
CH951377A CH632252A5 (en) 1976-08-16 1977-08-16 Process for preparing novel prostaglandin analogues
CH703481A CH633543A5 (en) 1976-08-16 1981-11-03 Process for the preparation of novel prostaglandin analogs.

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH703481A CH633543A5 (en) 1976-08-16 1981-11-03 Process for the preparation of novel prostaglandin analogs.

Country Status (8)

Country Link
JP (1) JPS5323967A (en, 2012)
AU (1) AU505149B2 (en, 2012)
CH (2) CH632252A5 (en, 2012)
DE (1) DE2736782A1 (en, 2012)
FR (1) FR2362130A1 (en, 2012)
GB (1) GB1540049A (en, 2012)
HU (1) HU180103B (en, 2012)
NL (1) NL7708963A (en, 2012)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100192A (en) * 1977-04-18 1978-07-11 The Upjohn Company Inter-phenylene-PG amides
JPS5925443A (ja) * 1982-08-02 1984-02-09 Mitsubishi Electric Corp レ−ダ受信機の校正方法
US5213388A (en) * 1991-09-30 1993-05-25 Baker Franklin W Anti-theft vehicle seat apparatus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950363A (en) * 1975-03-10 1976-04-13 The Upjohn Company Prostaglandin cyclic ethers

Also Published As

Publication number Publication date
FR2362130A1 (fr) 1978-03-17
HU180103B (en) 1983-01-28
FR2362130B1 (en, 2012) 1984-12-21
AU2729277A (en) 1979-02-01
GB1540049A (en) 1979-02-07
JPS5323967A (en) 1978-03-06
CH633543A5 (en) 1982-12-15
JPS6148504B2 (en, 2012) 1986-10-24
AU505149B2 (en) 1979-11-08
NL7708963A (nl) 1978-02-20
DE2736782A1 (de) 1978-02-23

Similar Documents

Publication Publication Date Title
DE3153474C2 (en, 2012)
DE2322673A1 (de) Neue verbindungen vom prostaglandintyp und verfahren zu ihrer herstellung
US4112224A (en) Biheterocyclic-9,11-trideoxy-PGF compounds
JPS58154525A (ja) インタ−フエニレンプロスタグランジン化合物
CH625797A5 (en, 2012)
CH628884A5 (de) Verfahren zur herstellung neuer prostaglandin-analoga.
AT367747B (de) Verfahren zur herstellung von optisch aktiven oder racemischen prostaglandinen und ihren salzen
EP0099538A1 (de) Neue Carbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2726857A1 (de) 9 alpha, 11 alpha-epoxymethano- oder 11 alpha, 9 alpha-epoxymethano-9, 11,15-trideoxy-prostaglandin f-analoga
DE2330333C2 (de) 9-Desoxy-prosta-5,9(10),13-triensäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutischen Zubereitungen
US4281113A (en) 2,5-Inter-o-phenylene-3,4-dinor-6,9α-epoxy-6.beta.-5-iodo-PGF1 compounds
EP0105288B1 (de) Carbacycline, herstellung und verwendung
CH632252A5 (en) Process for preparing novel prostaglandin analogues
CA1175822A (en) 2,5-inter-o-phenylene-3,4-dinor-pgf and pgi compounds
DE2719901A1 (de) Pge- und 11-deoxy-pge-verbindungen mit einer methylengruppe am c-9
CH623570A5 (en, 2012)
CH634297A5 (de) Prostaglandin-analoga.
CH624929A5 (en, 2012)
DE2555210A1 (de) Neue analoga natuerlich vorkommender prostaglandine
DE2716075A1 (de) Neue zwischenprodukte und verfahren zur herstellung von thromboxan-analoga
CH638195A5 (de) Prostacyclinanaloge.
CH646163A5 (de) Thromboxananaloge.
EP0098794B1 (de) Neue Carbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CH626338A5 (en) Process for the preparation of prostaglandin analogues
DE2830100A1 (de) Neue prostaglandinanaloge

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased